Combinations with CDK4/6 inhibitors to treat cancers with mutations in both KRAS and CDKN2A.Lacey Litchfield,Avnish Kapoor,Wenjuan Wu,Xueqian Gong,Yue Webster,Sheng-Bin Peng,Shripad Bhagwat,Farhana Merzoug,Sean G. BuchananMOLECULAR CANCER RESEARCH(2020)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要